We are excited to announce that Bette Monnot-Chase has joined Drug Discovery Alliances as our new Director of Analytical and CMC. Bette will be available to support our clients’ CMC requirements in both analytical and project management capacities.
Bette brings over 25 years of pharmaceutical industry experience, supporting the development of groundbreaking therapeutical agents. She is highly skilled in managing project needs to deliver high-quality analytical methods, compliant APIs, robust formulations, and essential stability data.
Throughout her career, she has contributed to 4 approved NDAs, 2 MAA and numerous INDs/IMPDs demonstrating her commitment to innovation and excellence. Her extensive background also includes experience with various dosage forms, including parenteral, inhalation, oral solid and liquids.
Her expertise and leadership will be invaluable to our team as we continue to deliver high-quality solutions and support for drug discovery and development. Please join us in welcoming Bette to the Drug Discovery Alliances team!
Comments